Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms.
Schiavi MC, Zullo MA, Faiano P, D'Oria O, Prata G, Colagiovanni V, Giannini A, Di Tucci C, Perniola G, Di Donato V, Monti M, Muzii L, Benedetti Panici P.
Schiavi MC, et al. Among authors: di tucci c, di donato v.
Gynecol Endocrinol. 2017 Dec;33(12):942-945. doi: 10.1080/09513590.2017.1323859. Epub 2017 May 11.
Gynecol Endocrinol. 2017.
PMID: 28490209
Free article.